This is a clinical trial of antihypertensive pharmacologic treatment and, in a specific subset, cholesterol-lowering, in high-risk hypertensive patients. The purpose is to determine whether the incidence of coronary heart disease and myocardial infarction differs between diuretic treatment and three alternative antihypertensive pharmacologic treatments - a calcium antagonist, an ACE inhibitor, and an alpha adrenergic blocker. As of February 2000, we have enrolled 53 patients. Enrollment is closed and we are now in the follow-up period. Future plans are to monitor for cardiovascular events and maintain enrollees in the protocol. This year the PI hosted an appreciation dinner for study participants.
Showing the most recent 10 out of 396 publications